1312 related articles for article (PubMed ID: 12279918)
21. Time to end bias against the pill.
Potts M
Entre Nous Cph Den; 1992 May; (20):10-1. PubMed ID: 12222224
[TBL] [Abstract][Full Text] [Related]
22. [Disease and contraception. Recent aspects].
Rozenbaum H
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):431-6. PubMed ID: 12280211
[TBL] [Abstract][Full Text] [Related]
23. IPPF statement on oral contraceptives and cancer of the breast.
International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
IPPF Med Bull; 1989 Apr; 23(2):4. PubMed ID: 12342374
[TBL] [Abstract][Full Text] [Related]
24. Contraception and the big "C".
Chandran R
Malays J Reprod Health; 1992 Jun; 10(1):1-5. PubMed ID: 12345024
[TBL] [Abstract][Full Text] [Related]
25. Results of oral contraceptive epidemiologic studies regarding neoplastic and cardiovascular effects.
Grimes DA
Int J Fertil; 1989; 34 Suppl():27-33. PubMed ID: 2576254
[TBL] [Abstract][Full Text] [Related]
26. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer.
Kaunitz AM
J Reprod Med; 1996 May; 41(5 Suppl):419-27. PubMed ID: 8725705
[TBL] [Abstract][Full Text] [Related]
27. New study shows OCs don't reduce rheumatoid arthritis risk.
Contracept Technol Update; 1985 Jan; 6(1):12-3. PubMed ID: 12279913
[TBL] [Abstract][Full Text] [Related]
28. Oral contraceptives and breast cancer: any relationship?
Peterson HB; Wingo PA
Contemp Oncol; 1992 Dec; 2(10):13-14, 19-20, 2. PubMed ID: 12345964
[TBL] [Abstract][Full Text] [Related]
29. Oral contraceptives have beneficial effects.
PIACT Prod News; 1982 Aug; 4(2):1, 4. PubMed ID: 12311600
[TBL] [Abstract][Full Text] [Related]
30. Oral contraceptives and cancer.
FDA Drug Bull; 1984 Apr; 14(1):2-3. PubMed ID: 6734989
[TBL] [Abstract][Full Text] [Related]
31. Risks of oral contraceptive use in women over 35.
Stenchever MA
J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860
[TBL] [Abstract][Full Text] [Related]
32. Oral contraceptives and cancer.
Edgren RA
Int J Fertil; 1991; 36 Suppl 3():37-50. PubMed ID: 1687403
[TBL] [Abstract][Full Text] [Related]
33. [Cutaneous effects in hormonal contraception].
Thomas P; Dalle E; Revillon B; Delecour M; Devarenne-nicolle MF; Pagniez I
NPN Med; 1985 Jan; 5(81):19-24. PubMed ID: 12281276
[TBL] [Abstract][Full Text] [Related]
34. OCs are currently the second most popular birth control method in U.S.
Contracept Technol Update; 1985 Jan; 6(1):3. PubMed ID: 12279916
[TBL] [Abstract][Full Text] [Related]
35. Oral contraceptives and neoplasia.
Stubblefield PG
J Reprod Med; 1984 Jul; 29(7 Suppl):524-9. PubMed ID: 6481705
[TBL] [Abstract][Full Text] [Related]
36. Dispelling OC myths and misperceptions.
Grimes DA
Dialogues Contracept; 1994; 4(3):1-4. PubMed ID: 12345574
[TBL] [Abstract][Full Text] [Related]
37. [Vascular disease and hormonal treatment--epidemiology].
Vessey MP
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):121-6. PubMed ID: 12280197
[TBL] [Abstract][Full Text] [Related]
38. The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study.
Hannaford PC; Kay CR
Br J Gen Pract; 1998 Oct; 48(435):1657-62. PubMed ID: 10071398
[TBL] [Abstract][Full Text] [Related]
39. Oral contraception: where do we stand?
Diczfalusy E
Contemp Rev Obstet Gynaecol; 1992 Jul; 4(3):148-53. PubMed ID: 12287020
[TBL] [Abstract][Full Text] [Related]
40. [The present state of research on the relationship of oral contraceptives to breast cancer].
Pike MC
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):329-38. PubMed ID: 12280203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
